Support from readers like you keeps The Journal open.
You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.
If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.
THE DEATH OF a guest on the Jeremy Kyle Show, which led first to its suspension and then to its axing, raises serious issues regarding the role of the daytime TV talk show as a programme format.
This type of show is difficult to place into a strict classification. But in both the US and the UK a type of entertainment uniquely suited to the demands of television has evolved.
The daytime talk show, at its best, combines some of the principal qualities of other successful dramatic forms – the emotional intimacy of melodrama and elements of comedy, while at the same time being able to offer a compelling immediacy which no work of TV fiction can provide.
Advertisement
The versatility of these shows allows them to straddle the genres within television, from journalism to melodramatic soap opera.
In America, The Oprah Winfrey Show was a forerunner of the intimate audience discussion programme.
Oprah initially opted for opposition rather than pluralism but later limited her format to discrete disclosures and consciousness-raising issues and offered less talk-time to confessionals.
On programmes like Jeremy Kyle, ITV’s long-running daytime show, the audience (in the studio and at home) was encouraged to tell its own stories, to agree or disagree and to confront or support the speaker – generating a cacophony of narratives on and beyond the small screen.
The host
Within the framework of the talk show genre, there exists a certain ambiguity concerning the role of the host.
Is he or she the chairperson of a debate, the referee, a conciliator, a judge, the compère of a game show or a therapist?
At times, the host can play any one of these roles, moving between debate and therapy session.
Over the years, Jeremy Kyle’s offering moved in the direction of the American voyeuristic talk show, The Jerry Springer Show.
Stories are told of mothers taking a stand against abusive fathers or teenagers telling of their battle with eating disorders or substance abuse.
All of these real-life traumas increase audience identification. Some of these programmes can create a type of ‘therapy genre’, that generates a supportive intimacy (but only for the duration of the programme).
Therapeutic insights may have been temporarily gained but many television critics and mental health campaigners have been sceptical of this genre, citing its dangers for participants.
Shows like Jeremy Kyle and Jerry Springer walk a precarious line between sympathy and sensationalism. These shows encourage a type of confession that may amount to exploitation.
In 2008, the Guardian newspaper reported that people with serious mental health issues were being publicly humiliated on the Jeremy Kyle Show. The stepmother of a guest said that she had repeatedly told the researchers of his mental health problems – but they still encouraged him to appear on the show.
This Tuesday, another former guest of Jeremy Kyle told the Guardian, that appearing on the show was the worst thing that had happened in his life and had made it difficult to secure employment.
While he received follow-up calls from production staff after his appearance, they were simultaneously uploading clips online of his appearance, accompanied by captions describing him as the rudest and most hated guest ever.
“It’s like stabbing someone in the back multiple times and then asking if the person is okay,” he said.
In 1996, on the US chat show, The Jenny Jones Show, a guest, Scott Amedure was fatally shot after the show by another guest, Jonathan Schmitz.
Amedure had revealed an attraction to Schmitz, who insisted he was heterosexual. The ensuing court case raised issues of broadcasting ethics and the irresponsibility and negligence of intentionally creating explosive situations without due concern for the possible consequences.
The initial jury award to the Amedure family was $25 million. This was later overturned by the Michigan Court of Appeal, due to its ‘chilling’ effect on the entertainment industry.
Rules in Ireland
Back home in Ireland, the Broadcasting Commission of Ireland implements strict codes and standards to hold all broadcasters to account and this is backed by rigorous oversight. We have strict programme guidelines and those who breach them, including by exploiting vulnerable guests, can expect to pay a large fine.
So it is hoped that we have sufficiently robust procedures here to ensure the welfare of TV guests, especially those that may be vulnerable.
Perhaps the UK regulators should examine those Irish codes and standards as well as our oversight regime.
They could start by ensuring that rigorous ‘ informed consent’ forms, similar to those signed by any vulnerable person who undergoes medical treatment, are in place.
Following the tragic outcome from the Jeremy Kyle Show, it is clear that far more needs to be done in the UK – not only to ensure the integrity of broadcasting but more importantly, the emotional and psychological welfare of all invited guests.
Dr Finola Doyle O’Neill is a Broadcast Historian at the School of History, UCC.
She lectures in Irish Media History and Crime and the Media in Ireland and is the author of The Gaybo Revolution: How Gay Byrne Challenged Irish Society.
Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.
Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.
To embed this post, copy the code below on your site
Close
56 Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic.
Please familiarise yourself with our comments policy
here
before taking part.
What we need is a Whole System that works,
It’s time to drain the sespool of leaders and show them with your VOTES , who are the real bosses , they work for us ,NOT the other way around
@Karllye kripton: the politicians don’t decide what drugs get approved, to do so would drive healthcare to a dystopian system to be decided by public opinion rather than expert medical professionals, so I’m unsure how votes would achieve your desired effect
@Vocal Outrage: Unfortunately this isn’t true. Look at Orkambi. Deemed to be not cost effective by the NCPE. Recommended not for reimbursement. Simon Harris decides to fund it. Despite this money coming at the expense of various other cost effective treatments. I wish the general public were fully aware of what a self serving decision this was, and how much it has cost the HSE, for a very marginal benefit, when you look at the overall CF population. But it looks good in the press.
@Peter Wheen: my point exactly, when you make populist medical policy decisions like that, against professional advice, then other parts of the service will suffer. I guess I was referring to how it should be
My mum was seen by many consultants in a private hospital in Dublin for pains that eventually had her bed ridden. After 4 months of various tests and different pain killers she took very ill and rushed to hospital. A simple CT scan not done previuosly by any consultant showed she was riddled with cancer and died the next day. My trust in private hospitals was questioned from that day onwards..
@Tom Padraig: Perhaps rather than blaming the medication, you should consider the circumstances that lead to people requiring antidepressants as opposed to labelling it all a scam.
@Philip Kavanagh: He is not wrong. One example would be the number of teens on Meds to treat their “ADHD” because they once told mummy to fork orf after eating a bag of skittles and downing five cans of red bull.
@Philip Kavanagh: As evidenced by the experience of those involved in the Air Corps chemical scandal, many if not most people on ADs do not need them. However they are the current quick “fix” for clinicians and a very lucrative one for industry.
The overprescription of ADs is a scourge & a scandal. The increase in anxiety & depression is being driven by what we eat, what we drink and what we breath.
ADs are one of the current unsustainable answers to an already unsustainable problem, counselling is the other.
Treating depression & anxiety along with so called suicide prevention is a fooking industry at this point.
@Ronan Sexton: He is wrong. Some people need antidepressants for a specific period, others will be on them for life. Like for most illnesses, medication is only one of the range of treatments. To write it all of as a scam is dangerous and stupid.
@Philip Kavanagh: The numbers on antidepressants in Ireland is simply staggering. To believe that all these people actually have mental health illnesses is simply beyond belief.
We are mass medicating a massive portion of our population out of ignorance.
I suppose the matter of not wasting billions on whats planned to be a multi tier health system for our kids in the supposed “best new hospital in the world (if you are wealthy and can afford expensive health insurance)”, would allow us buy a couple of billions more worth of drugs.
Can I ask if Dr. O’Connor believes, like a recently published Cork based gastroenterologist, that IBS is a psychosomatic illness?
“More than 50 per cent of my outpatients have symptoms caused by psychosomatic conditions, such as irritable bowel syndrome, which cannot be elucidated or cured by the molecular biologists”
@James Brady: Not really IBS and the like is overwhelming Gastroenterology Depts in all our hospitals. If all Gastroenterologists think IBS is psychosomatic then the problem is not being dealt with properly and is a further drain on the same pot of resources.
It stands to reason that if spending on expensive drugs means less money for other hospital spending then if something else is using up funds like for huge numbers of unnecessary “arse covering” endoscopy that then further eats into the same pool of money.
@Chemical Brothers: It’s not unnecessary. It is necessary to investigate or you can’t say with confidence that pt has IBS as opposed to something more serious. IBS is a diagnosis of exclusion. If gastroenterologist is arranging endoscopy to investigate, they are likely looking to rule out conditions with overlapping presentations such as coeliac, crohns, ulcerative colitis. When all investigations are negative and the symptoms are still of concern, it is not unreasonable to attempt treatments which have evidence of working in these cohorts of patients such as specific diets etc.
@Stephen Chaney: Thanks for reply. Considering the large percentage of those diagnosed with IBS in outpatient clinics would an approach of trying diet first rather than an expensive, invasive, unpleasant endoscopy procedure with attendant risk be a better course of action?
Is the endoscopy first approach being driven more by fear of missing a cancer and being sued for same rather than what may be a simpler approach?
Genuinely just asking, have had cameras both ends with nothing sinister found but have subsequently had success with dietary measures but not necessarily measures that consultants are familiar with.
In the UK there are set targets for delivery – something like Cancer surgery within 4 weeks maximum. If we set our public hospitals targets and then offered the patient free private care if not met that would focus minds on efficiencies.
@Pat Redmond: or just pay hospitals (and drs etc) per procedure. The countries with the shortest waiting lists are those with systems based on insurance where hospitals are paid like that.
he makes some valid points, but the chances of Ireland producing a high quality low cost health service are slim. We don’t do low cost for things like that in this country.
Great article and much that needs to be said- just would like to suggest another option- we need to recognise that the price tag on patented medicines bears no relationship to the cost of bringing the drug to market- but is the price unilaterally set by Pharma and is based on the maximum profit it can bring to its shareholders- which for life saving or life enhancing drugs is very high indeed. We need to bring some balance of power to the negotiating table to prevent monopoly abuse- ultimately by replacing the monopoly with an alternative incentive such as grants for R&D.
Ireland already has some medical deserts - and it’s been getting worse
Maria Delaney
3 hrs ago
1.5k
17
St Patrick's Day
Quiz: How much do you know about green things?
5 hrs ago
10.8k
United States
Tánaiste says Conor McGregor 'doesn't speak for Ireland' as MMA fighter arrives at White House
Updated
11 hrs ago
64.2k
Your Cookies. Your Choice.
Cookies help provide our news service while also enabling the advertising needed to fund this work.
We categorise cookies as Necessary, Performance (used to analyse the site performance) and Targeting (used to target advertising which helps us keep this service free).
We and our 157 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting Accept All enables tracking technologies to support the purposes shown under we and our partners process data to provide. If trackers are disabled, some content and ads you see may not be as relevant to you. You can resurface this menu to change your choices or withdraw consent at any time by clicking the Cookie Preferences link on the bottom of the webpage .Your choices will have effect within our Website. For more details, refer to our Privacy Policy.
We and our vendors process data for the following purposes:
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development.
Cookies Preference Centre
We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework.
Manage Consent Preferences
Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then these services may not function properly.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not be able to monitor our performance.
Store and/or access information on a device 109 partners can use this purpose
Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here.
Personalised advertising and content, advertising and content measurement, audience research and services development 141 partners can use this purpose
Use limited data to select advertising 111 partners can use this purpose
Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you).
Create profiles for personalised advertising 83 partners can use this purpose
Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities.
Use profiles to select personalised advertising 83 partners can use this purpose
Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects.
Create profiles to personalise content 38 partners can use this purpose
Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests.
Use profiles to select personalised content 34 partners can use this purpose
Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects. This can for example be used to adapt the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests.
Measure advertising performance 132 partners can use this purpose
Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns.
Measure content performance 60 partners can use this purpose
Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you.
Understand audiences through statistics or combinations of data from different sources 74 partners can use this purpose
Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents).
Develop and improve services 83 partners can use this purpose
Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers.
Use limited data to select content 38 partners can use this purpose
Content presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type, or which content you are (or have been) interacting with (for example, to limit the number of times a video or an article is presented to you).
Use precise geolocation data 46 partners can use this special feature
With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice.
Actively scan device characteristics for identification 27 partners can use this special feature
With your acceptance, certain characteristics specific to your device might be requested and used to distinguish it from other devices (such as the installed fonts or plugins, the resolution of your screen) in support of the purposes explained in this notice.
Ensure security, prevent and detect fraud, and fix errors 90 partners can use this special purpose
Always Active
Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them.
Deliver and present advertising and content 97 partners can use this special purpose
Always Active
Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device.
Match and combine data from other data sources 72 partners can use this feature
Always Active
Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice.
Link different devices 53 partners can use this feature
Always Active
In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices).
Identify devices based on information transmitted automatically 86 partners can use this feature
Always Active
Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice.
Save and communicate privacy choices 68 partners can use this special purpose
Always Active
The choices you make regarding the purposes and entities listed in this notice are saved and made available to those entities in the form of digital signals (such as a string of characters). This is necessary in order to enable both this service and those entities to respect such choices.
have your say